Conecte-se

Bibliografias temáticas / Beta adrenergic receptor blockaders / Livros

Siga este link para ver outros tipos de publicações sobre o tema: Beta adrenergic receptor blockaders.

Livros sobre o tema "Beta adrenergic receptor blockaders"

Autor: Grafiati

Publicado: 4 de junho de 2021

Última modificação: 21 de fevereiro de 2023

Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos

Selecione um tipo de fonte:

Veja os 25 melhores livros para estudos sobre o assunto "Beta adrenergic receptor blockaders".

Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.

Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.

Veja os livros das mais diversas áreas científicas e compile uma bibliografia correta.

1

Cruickshank, J. M. Beta-blockers in clinical practice. Edinburgh: Churchill Livingstone, 1988.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

2

Prichard, Brian N. C. 1932-, ed. Beta-blockers in clinical practice. Edinburgh: Churchill Livingstone, 1987.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

3

Drugs looking for diseases: Innovative drug research and the development of the beta blockers and the calcium antagonists. Dordrecht: Kluwer Academic Publishers, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

4

Advances in adrenergic receptor biology. Amsterdam: Elsevier, 2011.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

5

Owens, Helen. The effect of beta-adrenergic receptor antagonists on the temporal accommodative response. Birmingham: Aston University. Department of Vision Sciences, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

6

1944-, Costello J. F., e Mann Ronald D. 1928-, eds. Beta agonists in the treatment of asthma: The proceedings. Carnforth, Lancs, UK: Parthenon Pub. Group, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

7

Richard, Beasley, e Pearce Neil, eds. The Role of beta receptor agonist therapy in asthma mortality. Boca Raton: CRC Press, 1993.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

8

1946-, Frishman William H., ed. Beta₃-adrenergic agonism: A new concept in human pharmacotherapy. Armonk, N.Y: Futura, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

9

Cruickshank, J. M. Beta-Blockers in Clinical Practice. 2^a ed. W.B. Saunders Company, 1994.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

10

1948-, Deedwania Prakash C., ed. Beta-blockers and cardiac arrhythmias. New York: M. Dekker, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

11

1955-, Burch Ronald M., ed. Bradykinin antagonists: Basic and clinical research. New York: Dekker, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

12

H, Birkenhäger W., Folkow Björn e Struyker-Boudier H. A. J, eds. Adrenergic blood pressure regulation: Proceedings of a symposium, Corfu, 22-25 May 1984. Amsterdam: Excerpta Medica, 1985.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

13

R, Bühler Fritz, ed. The Cardioselectivity of bisoprolol. Montreal: PharmaLibri, 1989.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

14

The effect of training on beta adrenergic receptor number in rat heart. 1986.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

15

Beasley, Richard, e Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

16

Beasley, Richard, e Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

17

Beasley, Richard, e Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

18

Pearce, Neil, e Richard Beasley. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2019.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

19

Beasley, Richard, e Neil E. Pearce. Role of Beta Receptor Agonist Therapy in Asthma Mortality. Taylor & Francis Group, 2020.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

20

Frishman, William H., e Daniel E. Goldberg. Beta3 Adrenergic Agonism: A New Concept in Human Pharmacotherapy. Futura Publishing Company, 1995.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

21

Formoterol: A Long Acting B2-Agonist for the Management of Asthma : An International Symposium Held During the Joint Meeting of Sep and Sepcr, London. Hogrefe & Huber Pub, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

22

1936-, Saunders Kenneth B., European Society for Clinical Respiratory Physiology. e European Society of Pneumology, eds. Formoterol: A long-acting B2-agonist for the management of asthma : an international symposium held during the joint meeting of SEP and SEPCR, London, 1990. Seattle: Hogrefe & Huber, 1992.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

23

Formoterol. Hogrefe & Huber Pub, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

24

De Backer, Daniel, e Patrick Biston. Vasopressors in critical illness. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0034.

Texto completo da fonte

Resumo:

Vasopressors are used in various shock states to correct hypotension, aiming at restoring or improving organ and tissue perfusion. Vasopressor therapy may be associated with excessive vasoconstriction, but also metabolic and other side-effects. Hence, the ideal target for arterial pressure remains undetermined. Adrenergic agents remain the most commonly used vasopressor agents. Adrenergic agents increase arterial pressure through stimulation of alpha-adrenergic receptors. The effects of the different adrenergic agents differ mostly due to variable associated beta-adrenergic effects. Epinephrine and norepinephrine are strong and equipotent vasopressor agents. Their impact on outcome is as yet unanswered, but there is no sign that epinephrine might be associated with better outcomes. Accordingly, norepinephrine is the adrenergic agent of choice, especially in patients with cardiogenic shock. Vasopressin is a non-adrenergic vasopressor acting via V1 receptor stimulation, with weak vasopressor effects in normal conditions, but markedly increased vascular tone in shock states, especially in septic shock. Splanchnic vasoconstriction may occur. Arginine vasopressin at low doses appears to be a promising alternative to adrenergic agents, but its exact place is not yet well defined.

Estilos ABNT, Harvard, Vancouver, APA, etc.

25

1946-, Barnes Peter J., Matthys Heinrich e European Society of Pneumology. Congress, eds. Formoterol--a new-generation [beta] 2-agonist: An international symposium held during the 8th Congress of the European Society of Pneumology, Freiburg, Federal Republic of Germany, September 1989. Toronto: Hogrefe & Huber, 1991.

Encontre o texto completo da fonte

Estilos ABNT, Harvard, Vancouver, APA, etc.

Oferecemos descontos em todos os planos premium para autores cujas obras estão incluídas em seleções literárias temáticas. Contate-nos para obter um código promocional único!